Morpholine derivatives, compositions containing them and their use as
therapeutic agents
    1.
    发明授权
    Morpholine derivatives, compositions containing them and their use as therapeutic agents 失效
    吗啉衍生物,含有它们的组合物及其作为治疗剂的用途

    公开(公告)号:US5877316A

    公开(公告)日:1999-03-02

    申请号:US913566

    申请日:1997-09-16

    CPC分类号: C07D413/06

    摘要: The present invention relates to compounds of formula (I), wherein R.sup.1 and R.sup.4 represent hydrogen, halogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, C.sub.3-7 cycloalkyl, C.sub.3-7 cycloalkylC.sub.1-4 alkyl, C.sub.1-6 alkoxy, C.sub.1-4 alkyl substituted by a hydroxy or C.sub.1-4 alkoxy group, OCF.sub.3, hydroxy, trifluoromethyl, trimethylsilyl, nitro, CN, SR.sup.a, SOR.sup.a, SO.sub.2 R.sup.a, COR.sup.a, CO.sub.2 R.sup.a or CONR.sup.a R.sup.b, where R.sup.a and R.sup.b are each independently hydrogen or C.sub.1-4 alkyl; R.sup.2, R.sup.3 and R.sup.5 represent hydrogen, halogen, C.sub.1-6 alkyl, C.sub.1-4 alkoxy substituted by a C.sub.1-4 alkoxy group, or trifluoromethyl; R.sup.6 represents C.sub.1-6 alkyl, optionally substituted by oxo, substituted by a 5-membered heteroaromatic ring selected from oxazole, thiazole, isoxazole, isothiazole, oxadiazole and thiadiazole, wherein each heteroaromatic ring is substituted at the available carbon atom by a group of the formula: ZNR.sup.7 R.sup.8. The compounds are of particular use in the treatment of pain, inflammation, migraine and emesis.

    摘要翻译: PCT No.PCT / GB96 / 00587 Sec。 371日期:1997年9月16日 102(e)1997年9月16日PCT PCT 1996年3月13日PCT公布。 公开号WO96 / 29328 日期:1996年9月26日本发明涉及式(I)化合物,其中R 1和R 4表示氢,卤素,C 1-6烷基,C 2-6烯基,C 2-6炔基,C 3-7环烷基,C 3-7环烷基C 1-4烷基, C6烷氧基,被羟基或C1-4烷氧基取代的C1-4烷基,OCF3,羟基,三氟甲基,三甲基甲硅烷基,硝基,CN,SRa,SORa,SO2Ra,CORa,CO2Ra或CONRaRb,其中Ra和Rb各自独立地为氢或C1- 4个烷基; R2,R3和R5表示氢,卤素,C1-6烷基,被C1-4烷氧基取代的C1-4烷氧基或三氟甲基; R 6表示任选被氧代取代的,被选自恶唑,噻唑,异恶唑,异噻唑,恶二唑和噻二唑的5元杂芳环取代的C 1-6烷基,其中每个杂芳环在可用的碳原子上被一个式 :ZNR7R8。 该化合物特别用于治疗疼痛,炎症,偏头痛和呕吐。